Utibe R. Essien, MD, MPH
Physician Scientist | Assistant Professor | Coined #Pharmacoequity |Alum HSPH MGH Medicine Einstein Med | Opinions mine
- Reposted by Utibe R. Essien, MD, MPHA success story for a physician with Alzheimer's which, in spite of the obstacles outlined, is a precursor for our enhanced ability to prevent the disease in the future gift link www.wsj.com/opinion/i-ca...
- Reposted by Utibe R. Essien, MD, MPH[Not loaded yet]
- Glad to have contributed to this study examining #Pharmacoequity of newer disease modifying therapies for patients with rheumatoid arthritis. Take a look at our paper below! 📝: www.jrheum.org/content/52/1...
- Pharmacoequity turned 4 years old last month! Had a wonderful time in Ann Arbor last week as this year’s McKesson Equity Series Speaker @ the University of Michigan College of Pharmacy sharing on the past, present, and future of this growing field. Let’s work together to achieve #Pharmacoequity! 💊
- Had a wonderful time at the National Academy of Medicine (@nam.edu) Annual Meeting last week, kicking off Year 2 of the Emerging Leaders in Health and Medicine! ✨ Always great to connect with mentors, role models, and friends at this meeting and to celebrate the new inductees into the Academy.
- Every Wednesday evening for years I’ve opened the @nejm.org weekly email to dozens of the latest clinical trials of exciting new therapies. Yet, the future diffusion and equitable dissemination & implementation of these drugs is FAR less studied. So many opportunities to advance #Pharmacoequity. 💊
- Love the idea of a series focused on tobacco cessation globally, esp the role of #Pharmacoequity. 💊 But not sure there is evidence to support that it’s “lagging knowledge” driving ⬇️ rates of treatment in low and middle income countries. 🤔 Hoping for more data ahead. www.nejm.org/doi/full/10....
- My patient recently lost his Medicaid insurance and couldn’t afford his meds. Just calculated the cost of his 13 💊 which would be $2300/month. That’s around $27,500/year. The FPL for a family of 4 is ~$32,000. This is not sustainable for the health and lives of our patients! #Pharmacoequity
- Walked into a #RiteAid in CA yday that was EMPTY. Sad. “The hundreds of stores that are set to close within the year will limit many Americans' access to 💊 resulting in "pharmacy deserts"—less-connected communities being left w/o nearby drugstores. #Pharmacoequity www.newsweek.com/rite-aid-cvs...
- Reposted by Utibe R. Essien, MD, MPH[Not loaded yet]
- Reposted by Utibe R. Essien, MD, MPH[Not loaded yet]
- Reposted by Utibe R. Essien, MD, MPH[Not loaded yet]
- ‼️ New Simultaneous 📝 at #SGIM25. In 2023, lecanemab became the 1st disease-modifying 💊 for Alzheimer’s disease. Led by 🌟 Frank Zhou, we found that early uptake of lecanemab still appears to be marked by racial, ethnic & socioeconomic disparities. jamanetwork.com/journals/jam... #Pharmacoequity
- Congrats to the amazing, Renu! ✨
- Reposted by Utibe R. Essien, MD, MPH[Not loaded yet]
- Reposted by Utibe R. Essien, MD, MPH[Not loaded yet]
- ‼️ NEW Paper. Led by @sudkrishnamurthy.bsky.social we found wide disparities in receipt of ERBB2-targeted 💊 for Medicare enrollees w. breast cancer, disparities that did narrow by 2019. We need more research to identify strategies to improve cancer #Pharmacoequity. jamanetwork.com/journals/jam...
- Reposted by Utibe R. Essien, MD, MPH[Not loaded yet]
- Reposted by Utibe R. Essien, MD, MPHIn people with diabetes, GLP-1 and SGLT2i drugs were associated with less Alzheimer's disease and related dementias jamanetwork.com/journals/jam...
- NEW Academic Achievement Unlocked: Fellow of the American College of Physicians! ✨😅 Grateful to Dr. Eileen Barrett for the nomination and to my Dad, the first and best internal medicine doctor I know. 🤎👨🏾⚕️ #FACP cc @gradydoctor.bsky.social
- “…11% of people said they could not afford medication and care within the past 3 months, the highest level in the four years the survey has been conducted. Over 1/3 said if they were to need medical care, they would not be able to pay for it.” #Pharmacoequity www.nytimes.com/2025/04/02/h...
- Reposted by Utibe R. Essien, MD, MPH[Not loaded yet]
- Reposted by Utibe R. Essien, MD, MPH[Not loaded yet]
- Reposted by Utibe R. Essien, MD, MPH99% of new medicines developed by the pharmaceutical industry depend on NIH research jamanetwork.com/journals/jam...
- Had the pleasure of being invited (virtually) to both the University of Iowa College of Medicine and College of Dentistry to serve as a Distinguished Lecturer. 🖤💛 We need more than just talk right now to bring us closer to justice in health, but hoping to help inspire the future.
- Such a treat to have my friend and LEADER, Dr. Jasmine Marcelin, as our Department of Medicine Grand Rounds speaker. 👩🏾⚕️ Her talk, “Antimicrobial Prescribing Disparities and the Pursuit of #Pharmacoequity” was data-filled and inspiring. ✨
- Thanks to the *105-year-old* UCLA campus newspaper, the Daily Bruin, for this feature. 🗞️🐻 #HealthEquity dailybruin.com/2025/01/20/q...
- Reposted by Utibe R. Essien, MD, MPH[Not loaded yet]
- NEW: The next 15 drugs chosen for Medicare price negotiation have been announced by the administration. 💊 Perhaps unsurprisingly but importantly, the list includes Ozempic and Wegovy. #Pharmacoequity apple.news/Ah_4w14VjRgS...
- Reposted by Utibe R. Essien, MD, MPH[Not loaded yet]
- After acknowledging the fact that we both packed evacuation bags yday, spoke w. @usha.bsky.social about the new data on med school enrollment. “The number of Black enrollees fell by 11.6%… Hispanic enrollees ⬇️ 10.8%… American Indian or Alaska Natives ⬇️ by 22.1%.” www.statnews.com/2025/01/09/m...
- New study in JACC EP suggests no White vs. Black difference in the risk of device-detected #AFib. More data to seemingly debunk the “racial paradox” around AFib. Ealier AFib detection for ALL patients may help to eliminate wide stroke disparities. 📝: www.sciencedirect.com/science/arti...
- Reposted by Utibe R. Essien, MD, MPH[Not loaded yet]
- Nice overview in the American Journal of Health-System Pharmacy on how pharmacists can incorporate #Pharmacoequity into the formulary review process… …This will help ensure that the needs of vulnerable patient populations are being considered & addressed. academic.oup.com/ajhp/advance...
- Reposted by Utibe R. Essien, MD, MPH[Not loaded yet]
- Reposted by Utibe R. Essien, MD, MPH[Not loaded yet]
